Building confidence in circulating tumour DNA assays for metastatic castration-resistant prostate cancer

Affiliations

¹ Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
² Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. awwyatt@mail.ubc.ca.

Comment

Sarah W S Ng et al. Nat Rev Urol. 2021 May.

. 2021 May;18(5):255-256.

doi: 10.1038/s41585-021-00455-3.

¹ Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
² Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. awwyatt@mail.ubc.ca.

No abstract available

Comment on

Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms.
Tukachinsky H, Madison RW, Chung JH, Gjoerup OV, Severson EA, Dennis L, Fendler BJ, Morley S, Zhong L, Graf RP, Ross JS, Alexander BM, Abida W, Chowdhury S, Ryan CJ, Fizazi K, Golsorkhi T, Watkins SP, Simmons A, Loehr A, Venstrom JM, Oxnard GR. Tukachinsky H, et al. Clin Cancer Res. 2021 Jun 1;27(11):3094-3105. doi: 10.1158/1078-0432.CCR-20-4805. Epub 2021 Feb 8. Clin Cancer Res. 2021. PMID: 33558422 Free PMC article.

1. Merseburger, A. S. et al. Genomic testing in patients with metastatic castration-resistant prostate cancer: a pragmatic guide for clinicians. Eur. Urol. 79, 519–529 (2021). - DOI
1. Gonzalez, D. et al. Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer. J. Pathol. Clin. Res. https://doi.org/10.1002/cjp2.203 (2021). - DOI - PubMed
1. Maia, M. C., Salgia, M. & Pal, S. K. Harnessing cell-free DNA: plasma circulating tumour DNA for liquid biopsy in genitourinary cancers. Nat. Rev. Urol. 17, 271–291 (2020). - DOI
1. Wyatt, A. W. et al. Concordance of circulating tumour DNA and matched metastatic tissue biopsy in prostate cancer. J. Natl Cancer Inst. 109, djx118 (2017). - DOI
1. Tukachinsky, H. et al. Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer identifies targetable BRCA alterations and AR resistance mechanisms. Clin. Cancer Res. https://doi.org/10.1158/1078-0432.CCR-20-4805 (2021). - DOI - PubMed